Latest SEC Filings

Mentor Capital, Inc.Mentor Capital Reports Significant Revenue Increase in Q1 2026, Despite Net Loss

TRIO-TECH INTERNATIONALTrio-Tech International Reports 123.6% Revenue Growth to $16.5 Million in Latest Quarter

MARINE PETROLEUM TRUSTMarine Petroleum Trust Reports Decline in Revenue and Distributable Income for Three and Nine Months Ended March 31, 2026

STEELE BANCORP INCSteele Bancorp Reports 170% Increase in Net Income to $4.88 Million for Q1 2026

Tradewinds UniversalTradewinds Universal Reports 68% Revenue Growth but Incurred Net Loss in Latest Quarter

MOVING iMAGE TECHNOLOGIES INC.Moving iMage Technologies Reports Mixed Financial Results for Three and Nine Months Ended March 31, 2026

URBAN ONE, INC.Urban One Reports $77.7 Million Revenue in Q1 2026, Plans Strategic Asset Sales

HEALTHY EXTRACTS INC.Healthy Extracts Inc. Reports 73% Revenue Growth and Strategic Acquisition in Latest Quarterly Filing

YHN Acquisition I LtdYHN Acquisition I Limited Reports Q1 2026 Financial Results, Faces Challenges Ahead

XTI Aerospace, Inc.XTI Aerospace Reports $27.7 Million Revenue in Q1 2026, Significant Growth from Previous Year

Pulse Biosciences, Inc.Pulse Biosciences Reports First Revenue of $401,000 and Increased Net Loss in Q1 2026

Curanex Pharmaceuticals IncCuranex Pharmaceuticals Reports $3.15 Million Net Loss and Advances R&D Initiatives

HCM III ACQUISITION CORP.HCM III Acquisition Corp. Reports $1.72 Million Net Income in Q1 2026

National Vision Holdings, Inc.National Vision Holdings Reports $543.9 Million Revenue and $31.2 Million Net Income for Quarter Ended April 4, 2026

NON INVASIVE MONITORING SYSTEMS INC /FL/Non-Invasive Monitoring Systems Reports Increased Net Loss and Pursues Merger with Gravitics

Candel Therapeutics, Inc.Candel Therapeutics Reports $8.9 Million Net Loss Amid Increased Operating Expenses

QHSLab, Inc.QHSLab Reports Revenue Growth to $728,685 but Incurred Net Loss of $103,906 in Q1 2026

Synergy CHC Corp.Synergy CHC Corp. Reports Significant Revenue Decline and Net Loss in Q1 2026

Cingulate Inc.Cingulate Inc. Reports $9.3 Million Net Loss and $30.9 Million in Total Assets for Quarter Ending March 31, 2026

Benitec Biopharma Inc.Benitec Biopharma Reports $11.9 Million Net Loss for Quarter, Advances BB-301 Clinical Trial

Algorhythm Holdings, Inc.Algorhythm Holdings Reports $2.4M in Net Sales, $5.4M Net Loss for Quarter Ending March 31, 2026

Keros Therapeutics, Inc.Keros Therapeutics Reports Significant Revenue Decline and Net Loss in Q1 2026

CorMedix Inc.CorMedix Reports 226% Revenue Growth to $127.4 Million in Latest Quarter

Contango Silver & Gold Inc.Contango Silver & Gold Inc. Reports Significant Asset Growth and Acquisition of Dolly Varden Silver Corporation

Clene Inc.Clene Inc. Reports 81% Revenue Decline and $8.1 Million Net Loss in Q1 2026